The latest news:

• Musella Foundation Copay assistance program is now closed to new and renewal patients         We just awarded our 1,000th grant (of $5,000 each) to a brain tumor  patient in need of help today!   I know most people would rather donate to brain tumor research, but there is a huge need for this type of help also.    We give you a choice when making a donation - you can pick where your donation goes!  
  



• Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.        

  This study definitively proves what we already knew, that you do better if the entire tumor is removed. At a recent FDA advisory committee meeting I attended, the FDA said they did not believe that is the case.  Next time they will believe this study.  
  




• First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.         This is a big advance in brain tumor treatments. This new device allows the delivery of drugs to precisely where it is needed. Many clinical trials using convection enhanced delivery failed because the drug did not get to where it should have been.   Perhaps those trials should be redone using this system.  
  



• New Technology Crosses Blood-Brain Barrier To Fight Glioblastoma Cells Directly        Interesting new drug - apparently did well in phase 1 testing.
  



• Can all the money in the world beat cancer?         Maybe it could!  This person identified the collaboration between the Musella Foundation and Cancer Commons as one of the things he would fund if he raises all of that money!
  



• Study Reports Possible Novel Method for Stopping Untreatable Pediatric Brain Cancer         It is way too early to say it stops these pediatric brain tumors but this is a new idea that hopefully will start human clinical trials soon!
  

BrainTumor Co-Payment Assistance Program Status:

• CLOSED to new applicants